Companies / ACADIA Pharmaceuticals Inc

ACADIA Pharmaceuticals Inc

Nasdaq: ACADCIK 1070494SAN DIEGO, CAacadia-pharm.com ↗

Financials · FY2025

Revenue$1.07B
Net income$391.00M
Total debt—
Cash$384.99M
Diluted EPS$2.30
Shares outstanding172.3M

Ownership

172.3M shares outstanding · as of Jul 28, 2026
23.0%Insiders
Ownership
Insiders23.01%39,640,088
10%+ / strategic10.36%17,857,219
Institutions67.58%116,445,518
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 18

View all →
Insider% of sharesShares
Baker Bros. Advisors LPDirector · 10% owner
22.86%39,384,587
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
0.04%66,145
Harrigan EdmundDirector
0.03%43,148
Garofalo Elizabeth a.Director
0.02%33,489
Ndu AdoraDirector
0.02%32,908
Brege LauraDirector
0.01%23,202
Owen Adams CatherineCEOChief Executive Officer · Director
<0.01%14,803
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
<0.01%13,088
Daly James MDirector
<0.01%12,148
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC
<0.01%11,280

Institutional holders 342

View all →
HolderValue% of shares
Baker Bros. Advisors LP$954.88M24.90%
BlackRock, Inc.$569.63M13.07%
Vanguard Group Inc$404.76M8.79%
State Street Corporation$229.63M5.27%
RTW Investments, LP$190.83M4.15%
Point72 Asset Management, L.P.$90.21M1.96%
Dimensional Fund Advisors LP$78.02M1.70%
Geode Capital Management, LLC$77.14M2.01%
First Trust Advisors LP$74.43M1.94%
Palo Alto Investors LP$63.95M1.67%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 26, 2026Kihara James
Executive
SellCommon Stock$297.9K-11K
-46.60%
13,088
<0.01% of shares
medium
Mar 25, 2026Owen Adams Catherine
CEO
SellCommon Stock$249.9K-12K
-44.02%
14,803
<0.01% of shares
medium
Feb 9, 2026Rhodes Jennifer J
Executive
SellCommon Stock$162.5K-7K
-47.74%
7,609
<0.01% of shares
medium
May 26, 2026Kihara James
Executive
SellCommon Stock$114.4K-5K
-18.06%
24,509
0.01% of shares
medium
Mar 25, 2026Schneyer Mark C.
Executive
SellCommon Stock$89.7K-4K
-6.79%
57,299
0.03% of shares
low
Mar 25, 2026Rhodes Jennifer J
Executive
SellCommon Stock$82.5K-4K
-25.42%
11,280
<0.01% of shares
low
May 4, 2026Schneyer Mark C.
Executive
SellCommon Stock$76.4K-4K
-5.03%
66,145
0.04% of shares
low
Mar 25, 2026Thompson Elizabeth H.Z.
Executive
SellCommon Stock$73.7K-3K
-51.15%
3,280
<0.01% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
State Street CorporationPassive13G—9,076,212—
Vanguard Portfolio ManagementPassive13G—8,781,007—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ACAD——004225108—